Investor Presentaiton slide image

Investor Presentaiton

Department of Health Notes to the financial statements For the year ended on 30 June 2023 10.1.4 Explanatory statement for controlled operations (continued) Major Actual (2023) and Comparative (2022) Variance Narratives Contents 2023 Actual $'000 2022 Actual $'000 Variance $'000 A Supplies and services expenses 88,243 400,084 (311,841) Supplies and services expenses decreased by $311.8 million (-77.9%) due to COVID-19 related services ceasing operation. This includes reductions in the hotel quarantine facility ($106.5m), security ($106.4m), pathology ($85.2m) and clinical services ($13.1m). B Commonwealth grants and contributions income 2,698,931 3,256,004 (557,073) Commonwealth grants and contributions decreased by $557.1 million (-17.1%) reflecting the end of Commonwealth contribution towards the COVID-19 Response funded under the National Partnership Agreement which concluded in December 2022. 0 Inventories 37,275 45,022 (7,747) Inventories decreased by $7.7 million (-17.2%) due to medical equipment transferred to health service providers within the WA health system. D Infrastructure, property, plant and equipment 26,457 104,693 (78,236) Infrastructure, property, plant and equipment decreased by $78.2 million (-74.7%) due to modular units transferred to health service providers within the WA health system. E Supplies and services payments (792,231) (944,910) 152,679 Supplies and services payments decreased by $152.7 million (-16.2%) due to reduced contract services that supported the COVID-19 Response. F Commonwealth grants and contributions receipts 2,658,656 3,214,318 (555,662) Commonwealth grants and contributions receipts decreased by $555.7 million (-17.3%) reflecting the end of the Commonwealth contribution towards the COVID-19 Response funded under the National Partnership Agreement which concluded in December 2022. < 208 About us Significant issues Report on operations Agency performance Operational disclosures ⚫Key performance indicators Financial disclosures and compliance • Appendix
View entire presentation